Yu. S. Boriskin

808 total citations
25 papers, 618 citations indexed

About

Yu. S. Boriskin is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Yu. S. Boriskin has authored 25 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 9 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Yu. S. Boriskin's work include Virology and Viral Diseases (10 papers), Cytomegalovirus and herpesvirus research (5 papers) and Virus-based gene therapy research (4 papers). Yu. S. Boriskin is often cited by papers focused on Virology and Viral Diseases (10 papers), Cytomegalovirus and herpesvirus research (5 papers) and Virus-based gene therapy research (4 papers). Yu. S. Boriskin collaborates with scholars based in United Kingdom, Slovakia and France. Yu. S. Boriskin's co-authors include Stephen J. Polyak, Eve‐Isabelle Pécheur, Irina A. Leneva, James C. Booth, Lubov V. Dorofeeva, Akio Yamada, Philip D. Butcher, H. M. Steel, Kathleen Mathers and Paul N. Nelson and has published in prestigious journals such as Journal of Virology, Cellular and Molecular Life Sciences and Journal of General Virology.

In The Last Decade

Yu. S. Boriskin

22 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu. S. Boriskin United Kingdom 11 288 275 101 62 61 25 618
Julie Blaising France 7 195 0.7× 305 1.1× 130 1.3× 108 1.7× 35 0.6× 8 638
Véronique Joly France 20 251 0.9× 699 2.5× 143 1.4× 51 0.8× 48 0.8× 63 1.0k
Ilaria Vicenti Italy 19 222 0.8× 670 2.4× 123 1.2× 107 1.7× 63 1.0× 75 943
Teresa H. Bacon United Kingdom 12 597 2.1× 123 0.4× 142 1.4× 31 0.5× 79 1.3× 17 825
Jeong-Joong Yoon United States 16 434 1.5× 455 1.7× 180 1.8× 14 0.2× 108 1.8× 22 912
Daniel Brian Nichols United States 12 130 0.5× 339 1.2× 214 2.1× 57 0.9× 97 1.6× 18 701
Long V. Pham Denmark 13 185 0.6× 309 1.1× 141 1.4× 188 3.0× 29 0.5× 23 614
Gitanjali Subramanya United States 7 231 0.8× 438 1.6× 114 1.1× 166 2.7× 19 0.3× 8 793
Aesop Cho United States 15 254 0.9× 450 1.6× 326 3.2× 162 2.6× 168 2.8× 24 906
Gregory R. Bluemling United States 10 320 1.1× 663 2.4× 179 1.8× 20 0.3× 31 0.5× 15 901

Countries citing papers authored by Yu. S. Boriskin

Since Specialization
Citations

This map shows the geographic impact of Yu. S. Boriskin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu. S. Boriskin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu. S. Boriskin more than expected).

Fields of papers citing papers by Yu. S. Boriskin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu. S. Boriskin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu. S. Boriskin. The network helps show where Yu. S. Boriskin may publish in the future.

Co-authorship network of co-authors of Yu. S. Boriskin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu. S. Boriskin. A scholar is included among the top collaborators of Yu. S. Boriskin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu. S. Boriskin. Yu. S. Boriskin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boriskin, Yu. S., Irina A. Leneva, Eve‐Isabelle Pécheur, & Stephen J. Polyak. (2008). Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion. Current Medicinal Chemistry. 15(10). 997–1005. 324 indexed citations
2.
Boriskin, Yu. S., Eve‐Isabelle Pécheur, & Stephen J. Polyak. (2006). Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection. Virology Journal. 3(1). 56–56. 76 indexed citations
3.
Boriskin, Yu. S., R Powles, Ian B. Vipond, et al.. (2002). Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation. Journal of Clinical Virology. 24(1-2). 13–23. 14 indexed citations
4.
Boriskin, Yu. S., et al.. (1999). Is hepatitis C virus genotype 4 predominant in Saudi Arabia?. PubMed. 22(3). 173–80. 12 indexed citations
5.
Boriskin, Yu. S., et al.. (1999). Viral loads in dual infection with HIV-1 and cytomegalovirus. Archives of Disease in Childhood. 80(2). 132–136. 5 indexed citations
6.
Nelson, Paul N., Yu. S. Boriskin, Kathleen Mathers, et al.. (1996). A polymerase chain reaction to detect a spliced late transcript of human cytomegalovirus in the blood of bone marrow transplant recipients. Journal of Virological Methods. 56(2). 139–148. 23 indexed citations
7.
Aitken, Celia, James C. Booth, M Booth, et al.. (1996). Molecular epidemiology and significance of a cluster of cases of CMV infection occurring on a special care baby unit. Journal of Hospital Infection. 34(3). 183–189. 1 indexed citations
8.
Boriskin, Yu. S., James C. Booth, Catherine M. Corbishley, et al.. (1996). Human cytomegalovirus and acute rejection after heart transplantation are not directly associated. Journal of Medical Virology. 50(1). 59–70. 8 indexed citations
9.
Boriskin, Yu. S., James C. Booth, Sirimali Fernando, et al.. (1995). The detection of HIV-1 proviral DNA by PCR in clotted blood specimens. Journal of Virological Methods. 52(1-2). 87–94. 2 indexed citations
10.
Синицына, О. А., et al.. (1990). Further-attenuated measles vaccine: Virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo. Research in Virology. 141(5). 517–531. 19 indexed citations
11.
Dorofeeva, Lubov V., et al.. (1989). Experimental-scale measles and mumps vaccine production on microcarrier-grown cells. Vaccine. 7(6). 554–556. 7 indexed citations
12.
Boriskin, Yu. S., et al.. (1988). Laboratory markers for over-attenuation of mumps vaccine virus. Vaccine. 6(6). 483–488. 9 indexed citations
13.
Boriskin, Yu. S., et al.. (1988). Salt-induced enhancement of measles virus yields in cultured cells. Archives of Virology. 101(1-2). 131–136. 6 indexed citations
14.
Boriskin, Yu. S., et al.. (1987). Non-infectious morphologically altered nucleocapsids of measles virus from persistently infected cells. Archives of Virology. 95(1-2). 17–28. 10 indexed citations
15.
Foster, Keith, Kingsley Micklem, Gudrún Agnarsdóttir, et al.. (1983). Myxoviruses do not induce non-specific alterations in membrane permeability early on in infection. Archives of Virology. 77(2-4). 139–153. 9 indexed citations
16.
Boriskin, Yu. S., et al.. (1983). Accumulation of altered viral nucleocapsids in mumps virus?Persistently infected cell cultures. Archives of Virology. 75(4). 283–289. 3 indexed citations
17.
Boriskin, Yu. S., et al.. (1982). Mumps Virus-persistently Infected Cell Cultures Release Defective Interfering Virus Particles. Journal of General Virology. 63(2). 499–503. 15 indexed citations
18.
Boriskin, Yu. S., et al.. (1981). Comparative study of rabies virus persistence in human and hamster cell lines. Journal of Virology. 37(1). 1–6. 32 indexed citations
19.
Chelyapov, N. V., et al.. (1979). Tick-borne encephalitis virus-specified sequences in persistently infected cell culture revealed by DNA-DNA hybridization. Cellular and Molecular Life Sciences. 35(5). 601–602. 1 indexed citations
20.
Boriskin, Yu. S., et al.. (1978). Morphological characteristics of the infection of animals with tick-borne encephalitis virus persisting for a long time in cell cultures.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22(3). 218–24. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026